PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAB7. A total of 4 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $7,664,000,000 | -2.3% | 11,000,000 | 0.0% | 0.11% | -32.5% |
Q2 2016 | $7,844,000,000 | -2.2% | 11,000,000 | 0.0% | 0.17% | +15.0% |
Q1 2016 | $8,021,000,000 | -0.6% | 11,000,000 | 0.0% | 0.15% | +8.1% |
Q4 2015 | $8,070,000,000 | +8.6% | 11,000,000 | +10.0% | 0.14% | -9.9% |
Q3 2015 | $7,430,000,000 | -6.3% | 10,000,000 | 0.0% | 0.15% | +9.4% |
Q2 2015 | $7,929,000,000 | -8.0% | 10,000,000 | -9.1% | 0.14% | -25.0% |
Q1 2015 | $8,619,000,000 | -0.2% | 11,000,000 | 0.0% | 0.18% | +22.7% |
Q4 2014 | $8,635,000,000 | – | 11,000,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 4,000,000 | $2,698,000 | 2.68% |
Opaleye Management Inc. | 3,640,000 | $4,295,000 | 2.11% |
Mohican Financial Management, LLC | 2,600,000 | $1,851,000 | 1.41% |
Camber Capital Management LP | 9,000,000 | $6,182,000 | 0.53% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 18,872,000 | $13,435,000 | 0.21% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 10,000,000 | $7,430,000,000 | 0.15% |
ANGELO GORDON & CO., L.P. | 2,500,000 | $1,780,000 | 0.13% |
WOLVERINE ASSET MANAGEMENT LLC | 6,977,000 | $4,944,000 | 0.12% |
Baker Brothers Advisors | 3,423,000 | $2,450,000 | 0.02% |
FEDERATED HERMES, INC. | 5,330,000 | $3,631,000 | 0.01% |